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Abstract
Objective: To study the role of haemoglobin in outcome of thrombolysis after stroke. Material and method:
Our observational study was conducted over five years at KMC Hospital, Mangalore from July 2011 to July
2016. All patients above the age of 18 years presenting to the hospital within 4.5 hours of onset of stroke were
included into the study. The patients’ stroke severity was calculated by National Institute of Health Stroke Scale
(NIHSS) score, while the outcome was measured by Modified Rankin Scale (mRS) score. The patients were
divided into good outcome, poor outcome and expired group of patients depending on the mRS score (<3, ≥3 but
<6 and 6 respectively). The blood investigation haemoglobin was measured and recorded in all our patients. At
the end of the study, the significance was calculated by standard statistical methods. Result: 71.9% patients were
found to have good outcome, 24.2% patients had poor outcome and rest were in the expired group of patients.
Mean haemoglobin in the good outcome group amongst patients with thrombolysis was 12.8±1.3 gm/dl, while
that of poor outcome group was 12±1.2gm/dl. The haemoglobin of expired patients was 14.8±0 gm/dl (p
value- 0.0001). Conclusion: Our results suggest that haemoglobin levels need to be maintained in patients of
stroke treated with thrombolysis. Normal haemoglobin levels may have a neuroprotective action and may predict
a good outcome. On the other hand, high haemoglobin levels may lead to a poor outcome.
Key words: Blood transfusion, haemoglobin, hemodilution, mRS, neuroprotection, NIHSS, outcome of stroke,
polycythemia, stroke, thrombolysis

Introduction
Tissue surrounding the core infarct area is ischemic
but salvageable. This area is known as ischemic
penumbra and is the target of most of the therapies
for acute ischemic stroke. If blood flow is not
compromised, oxygen therapy might protect the
penumbra by preventing hypoxia that may expand
the stroke volume. Hypoxia (defined as sPO2<95%)
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has previously been known to cause harm in patients
of stroke. This warranted the use of oxygen
among patients presented with acute stroke and
had hypoxia.1 We studied whether the low oxygen
carrying capacity caused by low haemoglobin can
affect the outcome as well, in the Indian scenario.
Materials and methods
Our observational study was conducted over five
years at KMC Hospital, Mangalore from July 2011
to July 2016. All patients above the age of 18 years
presenting to the hospital within 4.5 hours of onset
of stroke were included in the study. The stroke
severity was calculated by National Institute of
Health Stroke Scale (NIHSS) score. The patients
were divided into three categories - good outcome,
poor outcome and expired, based on the Modified
Rankin Scale (mRS) score (<3, ≥3 but <6 and 6
respectively). The haemoglobin level was recorded
at the time of admission and these were correlated
with the outcome.
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Results
We were able to include 128 patients in our study.
The mean age of our patients was 62.5±13 years. A
slight male preponderance was noted in our patients
with 68 of the 128 (53.1%) patients being males. A
majority of our patients 114 of 128 (89.1%) were
found to have Middle Cerebral Artery territory
stroke, followed by Posterior Cerebral Artery
stroke (8.6%) and Anterior Cerebral Artery stroke.
The mean time of presentation to our hospital was
120±55 minutes with a door to needle time of 17±4
minutes (table 1).

haemoglobin in the good outcome group amongst
patients with thrombolysis was 12.8±1.3 gm/dl,
while that of poor outcome group was 12±1.2gm/
dl. The haemoglobin of expired patients was 14.8±0
gm/dl (p value- 0.0001).
Table 3: Haemoglobin (Hb) Profile in our Patients
Male

Female

Normal Hb

19

22

Mild Anemia

17

5

Moderate Anemia

1

4

Severe Anemia

0

0

Polycythemia

0

0

Table 1: Basic Details of Patients
Mean Age (years)

62.5±13

Male: Female

17:15

Mean time to presentation (min)

120±55

Door to needle time (min)

17±4

Mean NIHSS

22±7

ACA Stroke

2.30%

MCA Stroke

89.10%

PCA Stroke

8.60%

After analysis of thrombolysis by National Institute
of Neurological Disease and Stroke criteria of 1995,
92 of the 128 (71.9%) patients were found to have a
good outcome, 31(24.2%) patients had poor outcome
and five patients were in the expired group. The
mean NIHSS amongst our patients was 22±7 (table
2).
Table 2: Outcome and Haemoglobin in our Patients
Good
outcome
mRS<3

Poor
outcome
mRS ≥3 but
<6

Expired
mRS=6

Percentage
patients in
each group

71.90%

24.20%

3.90%

No. of
Patients

92 of 128

31 of 128

5 of
128

Haemoglobin
(gm%)

12.8±1.3

12.1±1.2

14.8±0

p
value

0.0001

By the WHO’s criteria, 19 males and 22 females had
normal haemoglobin; 17 males and 5 females had
mild anaemia; and 1 male and 4 female had moderate
anaemia. None of our patients had severe anaemia
or polycythemia (table 3). In our study, mean

Discussion
In our study, lower haemoglobin was associated
with poorer outcome of thrombolysis. The patients
also showed a U-shaped response curve. The low
haemoglobin and high haemoglobin were both
related to poor outcome.
In Lars Kellert et al., the baseline haemoglobin in
patients with good outcome was 14.1±1.4 gm/dl
while that in the poor outcome was 13.6±1.6 gm/
dl and this was found to be significant (p value0.016). The fate of the tissue after a stroke depends
upon timely reperfusion of the tissue. Therefore,
the oxygen carrying capacity of the blood, that is
haemoglobin, may play a decisive role in penumbral
destiny.2 It has been previously concluded that
supplemental oxygen therapy was beneficial for
patients of acute stroke, if the patient has associated
hypoxia.1, 3 Barlas et al. in their registry based in
UK also concluded that low haemoglobin adversely
affects the outcome in stroke. They also noted that
high haemoglobin was associated with a higher
mortality, especially within the first month of stroke.4
A U-shaped relationship has been demonstrated - a
poor outcome is expected with low as well as high
haemoglobin.2
The possible pathology that may explain the
association of anaemia with poor outcome have been
hypothesized. Lower haemoglobin due to anaemia
may cause a lower oxygen carrying capacity. This
lowered oxygen carrying capacity would lead to a
lower oxygen yield. This may therefore intensify the
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ischemia at the stroke site and contribute to hypoxia
within the penumbra.4,5,6 Besides, due to anaemia,
the cerebral auto regulation may be compromised.
There is an altered delivery of oxygen to the brain.
This may lead to a more turbulent flow to brain. This
may further trigger a migration of the thrombus or
cause atherothromboembolism. The hyper dynamic
circulation may also lead to increased expression on
adhesion molecules on the vascular endothelial cells.
This leads to a further brain damage during ischemia
due to up regulated production of inducible nitric
oxide synthase and CXC chemokine receptor.4, 7-13
Anaemia is common in India. It affects the outcome
and stay in the hospital in many conditions, including
stroke, where it is found in as many as 20% patients.
Anaemia has been defined as haemoglobin < 12 and
less than 13, in females and males respectively by
WHO.2 The WHO staging of anaemia is different
from that provided by ICMR for Indians. As per
WHO, haemoglobin in males and females above
13 and 12 gm/dl respectively, is normal. The mild
anaemia is haemoglobin of 11-12.9 and 11-11.9 in
males and females respectively. Moderate anaemia
was categorized as haemoglobin of 8-10.9 gm/dl
and severe anaemia was defined as less than 8 gm/
dl in both males and females.14 On the other hand,
as per ICMR, haemoglobin above 11 is normal.
Anaemia is classified as mild with haemoglobin
of 10-10.9 gm/dl, moderate with haemoglobin as
7-10 gm/dl, severe with haemoglobin of < 7gm/
dl and very severe with haemoglobin < 4gm/dl.15
Polycythemia has been known as haemoglobin of
more than 18 gm/dl in males and more than 16 gm/
dl in females.16
The haemoglobin in our patients was lower than
that in the study conducted previously. However,
the Caucasian population is known to have higher
haemoglobin compared to Indian population. This
is evident as the differences noted in grades of
anaemia in WHO and ICMR criteria. Similarly, our
study showed lower haemoglobin compared to the
Caucasian population studied, for example the study
by Kellert et al. 2
Raised haemoglobin has been found to have a poor
outcome in stroke. In fact, polycythemia is known
to present with a stroke. The raised haemoglobin
6
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is postulated to increase the blood viscosity. With
higher viscosity, the cerebral blood flow may
decrease. With reduced flow, platelet marginalization
increases further fulfilling the Virchow’s triad.
This mechanism has been accepted as a cause of
thrombosis causing stroke. A similar mechanism
may be the cause for the poor response seen in
patients with high haemoglobin. Polycythemia is
treated with hemodilution usually.17 The Multicenter
Austrian Hemodilution Stroke Trial has shown that
hemodilution does not influence death and outcome.18
Conclusion
We conclude that in patients undergoing
thrombolysis, haemoglobin levels need to be well
maintained. It can significantly affect the outcome
of stroke in patients undergoing thrombolysis.
We found that in Indian population also, low
haemoglobin as well as high haemoglobin may
adversely affect the outcome of thrombolysis. The
haemoglobin between 12 and 13 gm/dl in Indian
population yielded best results of thrombolysis in
patients who suffered stroke.
To the best of our knowledge, no study has
been performed on the effect of haemoglobin on
thrombolysis in stroke patients in India. Also,
we found no study that suggested a range of
haemoglobin that would suitably affect the outcomes
of thrombolysis in stroke. Patients with myocardial
infarction have shown improvement in outcomes with
correction of haemoglobin using packed red cells.19
However, to the best of our knowledge; no study or
guidelines have been yet published regarding the
correction of haemoglobin in thrombolysis for acute
stroke.
Conclusions of our study suggest that guidelines
regarding maintenance of haemoglobin levels
are needed. The intervention and treatment of
haemoglobin abnormalities may result in improved
outcomes of stroke post thrombolysis and this may
be an adjunctive therapy.
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